Skip to main content

Table 4 Predictive factors for overall survival after comparing the expected group and the group with the best response to therapy

From: A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

 

Univariate

Multivariate

    

MSKCC risk patients

Heng risk patients

Variables

OR

P-value

95 % CI

HR

P-value

95 % CI

HR

P-value

95 % CI

MSKCC Intermediate

0.12

0.001

0.03–0.44

0.12

0.003

0.03–0.49

   

Poor

0.04

0.040

0.01–0.86

0.04

0.041

0.01–0.87

   

DFI < 1 year

0.22

0.003

0.08–176.29

   

0.23

0.013

0.07–0.73

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us